# Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80

> **NCT00163566** · PHASE2 · COMPLETED · sponsor: **ASCEND Therapeutics** · enrollment: 128 (actual)

## Conditions studied

- Hypogonadism
- Late Onset Hypogonadism
- Low Testosterone

## Interventions

- **DRUG:** Dihydrotestosterone (0.7%) in hydroalcoholic gel

## Key facts

- **NCT ID:** NCT00163566
- **Lead sponsor:** ASCEND Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2006-09
- **Final completion:** 2006-09-25
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163566, "Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00163566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*